LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 94.68 | 17.25 | 7524 | 6239 | 1.2059 | 1.0446 | MN20160310_N02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 94.68 | 17.25 | 11 | 6239 | 0.0018 | -0.0516 | MN20160310_N02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 94.68 | 17.25 | 10152 | 6239 | 1.6271 | 1.1179 | MN20160310_N02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 94.68 | 17.25 | 1 | 6239 | 0.0002 | -0.2847 | MN20160310_N02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 94.68 | 17.25 | 14179 | 6239 | 2.2725 | 1.2028 | MN20160310_N02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 94.68 | 17.25 | 1 | 6239 | 0.0002 | -0.2847 | MN20160310_N02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 94.68 | 17.25 | 14834 | 6239 | 2.3775 | 1.2146 | MN20160310_N02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 3.06 | 17.25 | 1 | 143 | 0.0070 | -0.6065 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 3.06 | 17.25 | 297 | 143 | 2.0738 | 1.5397 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 3.06 | 17.25 | 6 | 143 | 0.0419 | -0.2924 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 3.06 | 17.25 | 272 | 143 | 1.8993 | 1.4676 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 5.03 | 17.25 | 1 | 273 | 0.0037 | -0.5106 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 5.03 | 17.25 | 545 | 273 | 1.9937 | 1.3780 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 5.03 | 17.25 | 9 | 273 | 0.0329 | -0.1506 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 5.03 | 17.25 | 450 | 273 | 1.6462 | 1.2664 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 7.01 | 17.25 | 4 | 389 | 0.0103 | -0.2775 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 7.01 | 17.25 | 783 | 389 | 2.0103 | 1.3360 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 7.01 | 17.25 | 14 | 389 | 0.0359 | -0.0454 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 7.01 | 17.25 | 623 | 389 | 1.5995 | 1.2202 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 8.98 | 17.25 | 4 | 445 | 0.0090 | -0.2678 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 8.98 | 17.25 | 882 | 445 | 1.9817 | 1.3141 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 8.98 | 17.25 | 14 | 445 | 0.0315 | -0.0436 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 8.98 | 17.25 | 762 | 445 | 1.7121 | 1.2430 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 10.95 | 17.25 | 6 | 471 | 0.0127 | -0.1985 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 10.95 | 17.25 | 918 | 471 | 1.9467 | 1.2996 | MN20160310_N02 | E16 |